Background
==========

Hepatocellular carcinoma (HCC) is the most common solid tumor worldwide, and is the leading factor responsible for cancer mortality \[[@b1-medscimonit-21-1072]\]. Most HCCs occur in China, Southeast Asia, and in parts of Africa \[[@b2-medscimonit-21-1072]\]. The main risk factors contributing to the occurrence of HCC are virus-induced chronic infection caused by hepatitis C virus (HCV) or hepatitis B virus (HBV), alcohol abuse, liver cirrhosis, exposure to aflatoxin B1, and diabetes \[[@b3-medscimonit-21-1072]\]. Among these, HBV is a major etiologic agent and is causes 80% of HCC cases. Furthermore, HBV-related liver disease is the major reason for liver transplantation \[[@b4-medscimonit-21-1072],[@b5-medscimonit-21-1072]\]. Research has estimated that both genetic and viral factors are crucial for the development of HCC; however, the exact mechanism leading to HBV tumorigenesis has not yet been fully elucidated \[[@b6-medscimonit-21-1072]--[@b8-medscimonit-21-1072]\].

HBV is a small, enveloped, double-stranded DNA virus. It contains 4 main regions: the pre-S/S region, the enhancer II region, basal core promoter region, and the precore region \[[@b9-medscimonit-21-1072]\]. Several HBV mutant strains in these regions were reported to contribute to the progression of liver disease \[[@b10-medscimonit-21-1072]\]. One of the most commonly reported HBV mutations is the pre-S region deletion mutation. The pre-S proteins are produced from the surface gene (S gene) region, including 3 different translation sites: pre-S1, pre-S2, and S \[[@b11-medscimonit-21-1072]\]. The pre-S protein is reported to be involved in hepatocyte attachment of the virus \[[@b12-medscimonit-21-1072]\] and contains B cell and T cell epitopes \[[@b13-medscimonit-21-1072]\]. The B cell and T cell epitopes are binding sites for neutralizing anti-pre-S2 antibody. An S promoter has been identified in pre-S that is associated with the production of middle and small HBs \[[@b11-medscimonit-21-1072]\]. The pre-S1 and pre-S2 regions are crucial for the interplay within the host immune responses \[[@b14-medscimonit-21-1072]\]. Numerous reports of mechanisms suggested that deletion mutations in pre-S in the integrated HBV DNA may impair the secretion of HBsAg, leading to increased endoplasmic reticulum and oxidative stress in hepatocytes \[[@b15-medscimonit-21-1072]\].

Recent studies have demonstrated that pre-S mutations affect the severity of liver disease; its mutation generally presents in the form of deletions \[[@b16-medscimonit-21-1072],[@b17-medscimonit-21-1072]\]. Studies have determined that mutation of the promoter sites of pre-S1 and pre-S2 significantly increase the risk of HCC development \[[@b18-medscimonit-21-1072],[@b19-medscimonit-21-1072]\]; however, a clinical study \[[@b20-medscimonit-21-1072]\] study has shown that the pre-S internal deletion mutants are unlikely to play crucial roles in hepatocarcinogenesis. These discrepancies may be due to genetic trait differences and different linkage disequilibrium. Therefore, in order to derive a more comprehensive estimation of the associations between pre-S deletion mutation and HCC risk, we conducted a meta-analysis to assess the relationship only among Asians.

Material and Methods
====================

Literature search
-----------------

An electronic literature search was conducted using PubMed, Embase, and China National Knowledge Infrastructure (CNKI) databases until September 30^th^, 2013. The Medical Subject Heading (MeSH) terms "hepatitis B virus," "HBV," "pre-S deletion," "mutation," "hepatocellular carcinoma", and the individual corresponding free terms were employed as the searching words. In addition, the citations in the retrieved articles were reviewed to search for relevant studies.

Criteria for article screening
------------------------------

The studies included met the following criteria: 1) assessed the association between pre-S mutations of HBV and HCC risk; 2) case-control or cohort study; 3) the diagnosis of liver disease followed the guidelines of the American Association for the Study of Liver Diseases \[[@b14-medscimonit-21-1072],[@b21-medscimonit-21-1072]\], and matched HBV-infected non-HCC cases as controls; 4) odds ratio with the 95% confidence interval (CI) was reported or could be determined from the available data; and 5) Asian population.

Data extraction
---------------

Two investigators independently assessed the extracted data from the included studies and reached a consensus on final results. Any disagreement was resolved by discussing with a third expert. The following information was extracted from all obtained publications: first author's name, publication year, country or area, the number of included patients, and the number of deletion mutations. We extracted data on the participants whose mutation status had been determined. Our evaluation included deletions in pre-S1 and/or pre-S2 that were predicted or known to decrease pre-S or S expression.

Statistical analysis
--------------------

Statistical analyses were carried out using Review Manager 5.2 (The Cochrane Collaboration). The crude odds ratios (ORs) and their corresponding 95% CI were used as a measure of the associations between HBV pre-S deletion mutation and risk of HCC. The overall effect was evaluated through the Z test. P value less than 0.05 was deemed to be statistically significant. The heterogeneity between all the included articles was evaluated by the Q test and the I^2^ statistics. P value less than 0.1 and I^2^ less than 50% was considered to be statistically significant. A fixed- or random-effects model was used to estimate the heterogeneity. A fixed-effects model was used when the effects were assumed to be homogenous, and a random-effects model was used when they were heterogenous. A funnel plot test was performed to examine publication bias.

Results
=======

Study selection
---------------

Our search strategy yielded 316 papers. We reviewed the titles, abstracts, and full texts of all retrieved articles using the defined criteria. Finally, 17 studies evaluating the relationship between pre-S deletion mutation of HBV and risk of HCC were selected in our meta-analysis. [Figure 1](#f1-medscimonit-21-1072){ref-type="fig"} shows the flow diagram. Characteristics of the included studies are shown in [Table 1](#t1-medscimonit-21-1072){ref-type="table"}. Of the 17 included studies, 8 were from mainland China \[[@b17-medscimonit-21-1072],[@b22-medscimonit-21-1072]--[@b29-medscimonit-21-1072]\], 3 were from Taiwan \[[@b16-medscimonit-21-1072],[@b30-medscimonit-21-1072],[@b31-medscimonit-21-1072]\], 1 was from Thailand \[[@b32-medscimonit-21-1072]\], 4 were from South Korea \[[@b33-medscimonit-21-1072]--[@b36-medscimonit-21-1072]\], and 1 was from mixed Asian countries \[[@b37-medscimonit-21-1072]\]. These studies included 2837 HBV-infected participants, of whom 1246 had HCC.

Pre-S deletions and the risk of HCC
-----------------------------------

We mainly focused on the pre-S deletion mutation in this meta-analysis. As shown in [Figure 2](#f2-medscimonit-21-1072){ref-type="fig"}, we observed a statistically significant association between pre-S deletion mutation and HCC risk. The data show that patients with HCC had more HBV with pre-S deletions than patients without HCC (35.7% *vs.* 11.5%). The overall risk estimates OR for HCC of pre-S deletion was 3.90 (95% CI=2.80--5.44, P\<0.00001) in a random-effects model. When only considering the Chinese population, our results found that the pre-S deletions were significantly associated with HCC risk (OR=4.84, 95% CI=2.86--8.20, P\<0.00001).

Sensitivity analysis
--------------------

For this meta-analysis, the ORs were not significantly changed by deleting any single study, indicating that no individual study affected the statistical significance of the overall results.

Publication bias
----------------

Publication bias was found in pre-S deletion mutation studies and funnel plot analysis showed that the study by Yin et al. was the outlier. After removing this study, the between-study heterogeneity decreased from 59% to 20%. [Figure 3A, 3B](#f3-medscimonit-21-1072){ref-type="fig"} display the funnel plots for the associations between pre-S deletion and HCC risk before and after omitting this report.

Discussion
==========

The pre-S region of HBV is located at 5′ of the S gene, and pre-S is composed of pre-S1 and pre-S2. Natural pre-S mutations of HBV have been frequently observed in chronic HBV infections \[[@b38-medscimonit-21-1072]\]. Pre-S region deletion mutation is known to be a risk factor for hepatocarcinogenesis and often occurs in patients treated with interferon. This suggests attempts by the virus to evade host immune response \[[@b39-medscimonit-21-1072]\]. Pre-S1 region deletion and pre-S2 region deletion are 2 common variants in the pre-S region. The deletion in the pre-S region results in the dysfunctional immune response and hepatocyte pathogenesis \[[@b40-medscimonit-21-1072]\], finally leading to the occurrence of HCC. Thus, these mutations might be used as biomarkers in predicting the development of HCC.

We identified an association of pre-S deletion mutation with HCC risk in this meta-analysis. The results showed that pre-S mutation statistically correlates with the significantly increased risk of HCC. The pooled crude ORs from the included studies suggest that pre-S mutation is associated with 4.64-fold increased risk of HCC compared with wild-type HBV (without mutations) (95% CI= 2.92--8.12, P\<0.00001) in a random-effects model.

To determine if specific pre-S mutations correlate with increased risk of HCC occurrence, we compared and analyzed the deleted portions of pre-S region in HBV-infected patients with or without HCC. We found that the 5′-terminal half of pre-S2 (nucleotides 3206-60) was the most commonly deleted portion of the pre-S region but that the frequency of this deletion in patients with and without HCC showed no significant statistical difference.

Although many studies have suggested the close relationship of pre-S deletions with the prevalence of HCC, they were mainly based on cross-sectional studies without thoroughly considering various possible confounding factors. Male sex, older age, and infection with HBV are the main risk factors for HCC occurrence \[[@b41-medscimonit-21-1072],[@b42-medscimonit-21-1072]\]. Older age and HBV genotype C are closely linked to the presence of pre-S deletions \[[@b18-medscimonit-21-1072],[@b43-medscimonit-21-1072]\]. The potential effect of the interaction of these factors should be considered in studying the role of pre-S deletions in HCC development in further research.

Several potential limitations exist in this meta-analysis. First, the observed association is substantially based on cross-sectional studies without considering other possible confounding factors. Second, publication biases cannot be completely excluded because all of the included studies were mainly relying on observation. Third, our study only focused on pre-S deletion mutation and we needed to also identify single-base substitutions at the pre-S1 and pre-S2 start codon. Fourth, all studies utilized in this meta-analysis were performed in eastern Asia, where HBV is endemic. Fifth, the control cases were not consistent; therefore, our results may not be generalizable to populations infected by other HBV genotypes. Furthermore, articles published in other languages were not incorporated into this analysis due to the anticipated difficulties in acquiring accurate medical translation.

Conclusions
===========

Despite the above limitations, our results show that pre-S mutations are associated with the increased risk of HCC development. However, large-scale, well-designed, case-control studies concentrating on the epigenetic influence and the genetic variations are still needed to prove this association.

**Conflict of interests**

None.

**Source of support:** This study is supported by Jinan science and technology plan projects, No: 201408020

![Studies identified with criteria for inclusion and exclusion.](medscimonit-21-1072-g001){#f1-medscimonit-21-1072}

![Forest plot for the correlation between pre-S deletion and HCC risk. Pooled odds ratio for the association of pre-S deletion mutation and HCC risk using random-effects model.](medscimonit-21-1072-g002){#f2-medscimonit-21-1072}

![Funnel plots analysis to detect publication bias of pre-S deletion mutation before (**A**) and after (**B**) three studies omitting. Each point represents an independent study for the indicated association.](medscimonit-21-1072-g003){#f3-medscimonit-21-1072}

###### 

Characteristics of studies included in this meta-analysis.

  First author   Year   Country          Mean age      Control type   Sample size   No. of deletion mutations        
  -------------- ------ ---------------- ------------- -------------- ------------- --------------------------- ---- ----
  Choi MS        2007   Korean           51.9±7.8      39.4±12.2      AC+CH+LC      72/228                      11   16
  Gao ZY         2007   China            55.56±12.28   20.04±0.89     AC+CHB        26/53                       10   3
  Mun H          2008   Korean           47.9±17.3     47.9±17.3      AC+CH+LC      40/80                       21   16
  Fang ZL        2008   China            30--55        30--55         Non-HCC       33/33                       15   6
  Chen C         2008   Taiwan           50.7±11.3     48.9±10.6      Non-HCC       80/160                      28   27
  Cao ZG         2008   China            42.1±8.8      39.9±12.4      CH            47/50                       24   9
  Jang JS        2009   South Korea      --            --             Non-HCC       48/71                       17   13
  Abe K          2009   Four countries   11±3          6±5            CH            30/10                       23   0
  Wu XD          2010   China            46.7±10.7     45.8±13.3      AC            44/43                       21   6
  Yin JH         2010   China            49.9±11.0     30.0±16.9      AC            231/603                     94   43
  Huang H        2010   Taiwan           12.7±6.6      12.3±0.8       CH            19/19                       9    1
  Yeung P        2011   Taiwan           56.9±11.5     56.8±11.5      Non-HCC       96/96                       28   14
  Qiang FL       2011   China            42--67        21--39         AC            26/25                       6    0
  Lee MH         2011   Korean           44.3±7.8      44.3±8.0       Non-HCC       135/135                     25   6
  Thongbai C     2013   Thailand         58.1±12.0     41.3±8.8       Non-HCC       65/89                       11   9
  Zhao ZM        2014   China            --            --             Non-HCC       157/160                     74   45
  Qu LS          2014   China            44.2±9.5      45.0±8.3       Non-HCC       97/96                       28   11

AC -- asymptomatic carrier; CH -- chronic hepatitis; LC -- liver cirrhosis; HCC -- hepatocellular carcinoma; '--' -- not applicable.
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